Skip to content

D&A at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$44.6M+14.1%
Amcor logo
AmcorAMCR
$377M+186%
Nordson logo
NordsonNDSN
$36.32M-3.4%
Baxter International logo
Baxter InternationalBAX
$237M-4.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$4.22M+57.1%
AVT
AvantorAVTR

Segments

By segment

See full
Pharma$35.64M+14.4%
Beauty$24.72M+23.2%
Closures$14.22M+4.8%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's D&A?
AptarGroup (ATR) reported D&A of $64.31M in Q1 2026.
How has AptarGroup's D&A changed year-over-year?
AptarGroup's D&A increased by 17.1% year-over-year, from $54.9M to $64.31M.
What is the long-term trend for AptarGroup's D&A?
Over 4 years (2021 to 2025), AptarGroup's D&A has grown at a 5.7% compound annual growth rate (CAGR), from $193.78M to $242.31M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.